Systemic Lupus Erythematosus 2 Flashcards
What is a severe complication of SLE
Lupus nephritis
- renal involvement causes scarring and destruction of renal tissue
- classified as class 1-6, indicating amount of damage
give examples of neuropsychiatric complications of SLE
- cognitive dysfunction
- anxiety disorder
- mood disorder
what is iatrogenic lupus
lupus caused by use of certain drugs
- drug induced lupus
give examples of drugs that may be associated with SLE
- carbamazepine
- levodopa
- omeprazole
what should be checked if a patient is positive for lupus
check ANAs
what is involved in the management of non renal and non CNS lupus
- NSAIDs- caution with renal function
- hydroxychloroquine
- glucocorticoids- lowest dose for shortest period of time
outline the treatment of neuropsychiatric lupus
- establishment of NPSLE diagnosis
- cerebrospinal fluid examination
- autoantibody profile
- neuroimagaing to assess brain structure - identification of aggravating factors
- hypertension, infection, metabolic abnormalities - symptomatic therapy
- anticonvulsants, psychotropics - cognitive rehabilitation
- immunosuppression
- corticosteroids, azathioprine - anticoagulation- heparin, warfarin
how many classes of renal involvement are there
6 classes
- 1st class= minimal involvement
-6th class= most severe
what are the 2 main phases involved in the treatment of lupus nephritis
- acute induction of remission
- maintenance of remission
outline the treatment of lupus nephritis
- gold standard: IV cyclophosphamide pulse therapy (rapid) in combination with glucocorticosteroids
- can quickly establish remission and prevent organ failure - must also include a maintenance strategy
what can azathioprine, mycophenalate and ciclosporin be used for in lupus nephritis
they are remission inducing and maintenance therapies
- if used correctly, can maintain remission at high rates
- seldom used for induction and IV cyclophosphamide is standard therapy
describe the 2 phases of treatment of lupus nephritis and how does having 2 treatment phases affect treatment choice
- induction of remission and maintenance of remission
- we want a fast acting drug first to get the patient into remission, and then using a less toxic, slower acting drug to keep them in remission
- so we need to choose a drug that is effective for treating each phase